Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Liabilities and Shareholders Equity (2023 - 2026)

Astera Labs has reported Liabilities and Shareholders Equity over the past 3 years, most recently at $1.5 billion for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 45.26% year-over-year to $1.5 billion, compared with a TTM value of $5.3 billion through Dec 2025, up 39.5%, and an annual FY2025 reading of $1.5 billion, up 45.26% over the prior year.
  • Liabilities and Shareholders Equity came in at $1.5 billion for Q4 2025, up from $1.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.5 billion in Q4 2025 to a low of $196.3 million in Q4 2023.
  • Median Liabilities and Shareholders Equity over the past 3 years was $1.1 billion (2024), compared with a mean of $1.0 billion.
  • The sharpest move saw Liabilities and Shareholders Equity soared 437.21% in 2024, then rose 29.69% in 2025.
  • Over 3 years, Liabilities and Shareholders Equity stood at $196.3 million in 2023, then soared by 437.21% to $1.1 billion in 2024, then skyrocketed by 45.26% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ALAB's Liabilities and Shareholders Equity are $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.3 billion (Q2 2025).